Latest Vida Ventures Advisors, LLC Stock Portfolio
$180Million
Equity Portfolio Value
Last Reported on: 12 Apr, 2024
About Vida Ventures Advisors, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Vida Ventures Advisors, LLC reported an equity portfolio of $180 Millions as of 31 Mar, 2024.
The top stock holdings of Vida Ventures Advisors, LLC are , CNTA, DYN. The fund has invested 62.4% of it's portfolio in KYVERNA THERAPEUTICS, INC. and 24.7% of portfolio in CENTESSA PHARMACEUTICALS PLC.
The fund managers got completely rid off LIANBIO (LIAN), KINNATE BIOPHARMA, INC. (KNTE) and IKENA ONCOLOGY, INC. (IKNA) stocks. They significantly reduced their stock positions in DYNE THERAPEUTICS, INC. (DYN). Vida Ventures Advisors, LLC opened new stock positions in KYVERNA THERAPEUTICS, INC..
The top stock holdings of Vida Ventures Advisors, LLC are , CNTA, DYN. The fund has invested 62.4% of it's portfolio in KYVERNA THERAPEUTICS, INC. and 24.7% of portfolio in CENTESSA PHARMACEUTICALS PLC.
The fund managers got completely rid off LIANBIO (LIAN), KINNATE BIOPHARMA, INC. (KNTE) and IKENA ONCOLOGY, INC. (IKNA) stocks. They significantly reduced their stock positions in DYNE THERAPEUTICS, INC. (DYN). Vida Ventures Advisors, LLC opened new stock positions in KYVERNA THERAPEUTICS, INC..
New Buys
| Ticker | $ Bought |
|---|---|
| KYVERNA THERAPEUTICS, INC. | 112,374,000 |
New stocks bought by Vida Ventures Advisors, LLC
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| DYNE THERAPEUTICS, INC. | -80.36 |
Vida Ventures Advisors, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| LIANBIO | -10,200,900 |
| KINNATE BIOPHARMA, INC. | -5,232,420 |
| IKENA ONCOLOGY, INC. | -443,628 |
Vida Ventures Advisors, LLC got rid off the above stocks
Current Stock Holdings of Vida Ventures Advisors, LLC
Last Reported on: 12 Apr, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ALLO | ALLOGENE THERAPEUTICS, INC. | 4.46 | 1,798,160 | 8,037,790 | UNCHANGED | 0.00 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 24.68 | 3,931,820 | 44,429,500 | UNCHANGED | 0.00 | |
| DYN | DYNE THERAPEUTICS, INC. | 6.43 | 407,499 | 11,568,900 | REDUCED | -80.36 | |
| IKNA | IKENA ONCOLOGY, INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KNTE | KINNATE BIOPHARMA, INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KRON | KRONOS BIO, INC. | 2.00 | 2,765,310 | 3,594,910 | UNCHANGED | 0.00 | |
| LIAN | LIANBIO | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| KYVERNA THERAPEUTICS, INC. | 62.43 | 4,523,920 | 112,374,000 | NEW |